AU3971800A - 2-alkoxy-cyclobutene-3,4-dione derivatives, preparation and therapeutic use thereof - Google Patents

2-alkoxy-cyclobutene-3,4-dione derivatives, preparation and therapeutic use thereof

Info

Publication number
AU3971800A
AU3971800A AU39718/00A AU3971800A AU3971800A AU 3971800 A AU3971800 A AU 3971800A AU 39718/00 A AU39718/00 A AU 39718/00A AU 3971800 A AU3971800 A AU 3971800A AU 3971800 A AU3971800 A AU 3971800A
Authority
AU
Australia
Prior art keywords
cyclobutene
alkoxy
preparation
therapeutic use
dione derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU39718/00A
Other languages
English (en)
Inventor
Philippe R Bovy
Claudie Gautier
Christophe Philippo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Sanofi Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo SA filed Critical Sanofi Synthelabo SA
Publication of AU3971800A publication Critical patent/AU3971800A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/24Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/08Drugs for disorders of the urinary system of the prostate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/02Systems containing only non-condensed rings with a three-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/04Systems containing only non-condensed rings with a four-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • Reproductive Health (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU39718/00A 1999-04-20 2000-04-11 2-alkoxy-cyclobutene-3,4-dione derivatives, preparation and therapeutic use thereof Abandoned AU3971800A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9904945 1999-04-20
FR9904945A FR2792634B1 (fr) 1999-04-20 1999-04-20 Derives de 2-alcoxy-cyclobutene-3,4-dione leur preparation et leur application en therapeutique
PCT/FR2000/000926 WO2000063160A1 (fr) 1999-04-20 2000-04-11 Derives de 2-alcoxy-cyclobutane-3,4-dione leur preparation et leur application en therapeutique

Publications (1)

Publication Number Publication Date
AU3971800A true AU3971800A (en) 2000-11-02

Family

ID=9544620

Family Applications (1)

Application Number Title Priority Date Filing Date
AU39718/00A Abandoned AU3971800A (en) 1999-04-20 2000-04-11 2-alkoxy-cyclobutene-3,4-dione derivatives, preparation and therapeutic use thereof

Country Status (6)

Country Link
AR (1) AR023548A1 (fr)
AU (1) AU3971800A (fr)
CO (1) CO5160305A1 (fr)
FR (1) FR2792634B1 (fr)
UY (1) UY26110A1 (fr)
WO (1) WO2000063160A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6495576B2 (en) 2001-02-07 2002-12-17 Abbott Laboratories Aminal diones as potassium channel openers
DE10135815A1 (de) * 2001-07-23 2003-02-06 Bayer Ag Verwendung von 2-Alkoxyphenyl-substituierten Imidazotriazinonen
US20050107394A1 (en) * 2001-12-17 2005-05-19 Ardeschir Ghofrani Novel use of selective pde5 inhibitors
FR2842271B1 (fr) 2002-07-15 2004-09-10 Eurocopter France Boite de transmissiion de puissance basculante a transfert de charge par le carter

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9311282D0 (en) * 1993-06-01 1993-07-21 Rhone Poulenc Rorer Ltd New compositions of matter

Also Published As

Publication number Publication date
CO5160305A1 (es) 2002-05-30
FR2792634B1 (fr) 2001-06-01
WO2000063160A1 (fr) 2000-10-26
FR2792634A1 (fr) 2000-10-27
AR023548A1 (es) 2002-09-04
UY26110A1 (es) 2000-12-29

Similar Documents

Publication Publication Date Title
AU3957600A (en) Piperidyl-imidazole derivatives, their preparations and therapeutic uses
AU2922600A (en) Pyridopyranoazepine derivatives, preparation and therapeutic use
AU2002340999A1 (en) Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use
HK1048999A1 (zh) 氮雜䓬吲衍生物,它們的製備和應用
AU3958100A (en) New compounds, their preparation and use
AU3958200A (en) New compounds, their preparation and use
AU2001282267A1 (en) Benzimidazole derivatives, preparation and therapeutic use thereof
AU3957900A (en) New compounds, their preparation and use
HUP0105039A3 (en) Fungicidal propargylether derivatives, preparation and use thereof
AU1164601A (en) Therapeutic use and formulation
HU0002848D0 (en) Cyclobutene derivatives, their preparation and their therapeutic uses
IL135451A0 (en) 3-amino-3-arylpropan-1-ol derivatives, their preparation and use
AU3971500A (en) Indazole derivatives, preparation and therapeutic application thereof
AU1243399A (en) Imidazole derivatives, preparation and therapeutic application thereof
AU5368699A (en) Derivatives of triptolide, and preparation and uses thereof
HUP0201810A2 (en) Sootepenseone and its derivatives, their preparation and use as medicament
AU6846500A (en) Novel 8-carbonyl chroman derivatives, preparation and therapeutic use thereof
AU1053501A (en) Polyazanaphthalene compound and medicinal use thereof
AU2001284084A1 (en) Polyfluoroalkyltriazole derivatives, preparation and therapeutic use thereof
AU3971800A (en) 2-alkoxy-cyclobutene-3,4-dione derivatives, preparation and therapeutic use thereof
HUP0203468A3 (en) Betha-d-5-thioxylose derivatives, preparation method and therapeutic use thereof
AU5524400A (en) Novel 6-amino-uracil derivatives, preparation and use thereof
AU1887301A (en) Heterocycle derivatives and drugs
AU2002229870A1 (en) Mikanolide derivatives, their preparation and therapeutic uses
IL135452A0 (en) 3-amino-3-arylpropan-1-ol derivatives, their preparation and use

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase